DOK3表达对HGC-27胃癌细胞增殖与侵袭迁移能力的影响

王伟; 李扬; 苏军华; 吕凌玲

doi:10.3969/j.issn.1671-038X.2020.11.12

DOK3表达对HGC-27胃癌细胞增殖与侵袭迁移能力的影响

- 1. 邯郸市第一医院外六科, 河北邯郸 056000;
- 2. 河北医科大学第二医院, 河北石家庄 050000
基金项目:
河北省医学科学研究重点课题(No:20180123)

详细信息

通讯作者: 苏军华,E-mail:1120237924@qq.com

中图分类号: R735.2

收稿日期: 2020-01-01

Effects of DOK3 gene expression on the proliferation,invasion and migration ability of HGC-27 gastric cancer cell

- 1. Department of Surgery, the First Hospital of Handan, Handan 056000, China;
- 2. The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China

More Information

Corresponding author: SU Jun-hua, E-mail: 1120237924@qq.com

Received Date: 01 January 2020

摘要

摘要: [目的]分析中晚期胃癌患者DOK3表达情况及对HGC-27胃癌细胞增殖与侵袭迁移能力产生的影响。[方法]选择120例2015年12月~2017年7月收治的胃部疾病患者,以其疾病类型差异分组,A组为低级别上皮内瘤变患者(20例),B组为高级别上皮内瘤变患者(40例),C组为慢性浅表性胃炎患者(40例),D组为中晚期胃癌患者(20例)。对其DOK3表达展开专业检测,并记录其HGC-27细胞组织增殖状况及其侵袭迁移状况。[结果]A组DOK3表达阳性率为60.00%,B组为50.00%,C组为82.50%,D组为35.00%,B组及D组比C组低,差异有统计学意义(P<0.05);C组与A组对比、A组与B组对比差异无统计学意义(P>0.05);对HGC-27细胞组织中DOK3基因展开敲降后,对于胃癌细胞组织的增殖产生促进作用,且细胞组织侵袭迁移作用会更为明显。[结论]胃部癌变现象发生的生物学指标之一即DOK3,且DOK3同时还是抑癌基因类型,在中晚期胃癌患者临床诊断中具有利用价值。
- 胃癌 /
- DOK3基因 /
- HGC-27细胞 /
- 侵袭 /
- 迁移
Abstract: [Objective]Analysis the DOK3 expression on the advanced gastric cancer patients and its influence on the proliferation of HGC-27 gastric cancer cells and invasive migration capability.[Methods]One hundred and twenty cases of gastric diseases patients was extracted from December 2015 to July 2017,randomly divided into control group and experimental group according to differences in disease types,group A has 20 cases of low grade intraepithelial neoplasia patients,group B has 40 cases of high-grade intraepithelial neoplasia patients,group C has 40 cases of chronic superficial gastritis patients,group C has 20 cases of advanced gastric cancer patients,all of these patients were detection of DOK3 expression,and record the proliferation and invasion and migration of HGC-27 cells.[Results]The positive rate of DOK3 expression in group A was 60.00%,group B was 50.00%,group C was 82.50%,and group D was 35.00%,group B and group D were lower than those of the group C,with statistically significant(P<0.05),there were no significant difference between group C and A,group A and B(P>0.05).After knock down the DOK3 gene in the cell organization of HGC-27,it can promote the proliferation of gastric cancer cell tissue,and the invasion and migration of cells and tissues will be more obvious.[Conclusion]One of the biological indicators of gastric carcinogenesis is DOK3,and DOK3 is also a tumor suppressor gene type,it has value in clinical diagnosis of patients with advanced gastric cancer.
- gastric cancer /
- DOK3 gene /
- HGC-27 cell /
- invasive /
- migration

HTML全文

参考文献(20)

[1]	翟頔,温馨,皮静楠,等.miR-363-3p在胃癌组织中的表达及其对细胞系HGC-27增殖、迁移与侵袭功能的影响[J].基础医学与临床,2016,36(5):638-643.
[2]	张海峰,申兴斌,刘莎莎,等.下调胰岛素样生长因子-1表达对人胃癌细胞增殖和侵袭及迁移的影响[J].中华肿瘤防治杂志,2017,24(1):16-22.
[3]	Bertuccio P,Alicandro G,Rota M,et al.Citrus fruit intake and gastric cancer:The stomach cancer pooling(StoP)project consortium[J].Int J Cancer,2019,144(12):2936-2944.
[4]	Praud D,Rota M,Pelucchi C,et al.Cigarette smoking and gastric cancer in the Stomach Cancer Pooling(StoP)Project[J].Eur J Cancer Prev,2018,27(2):124-133.
[5]	胡智慧,段亚男,韩鲁军,等.PFKFB3基因增强阿帕替尼对胃癌凋亡的影响及机制[J].中国中西医结合消化杂志,2019,27(7):495-500.
[6]	Ferro A,Rosato V,Rota M,et al.Meat intake and risk of gastric cancer in the Stomach cancer Pooling(StoP)project[J].Int J Cancer,2020 ,147(1):45-55.
[7]	Beyhan Cengiz,Onder Yumrutas,Esra Bozgeyik,et al.Differential expression of the UGT1 A family of genes in stomach cancer tissues[J].Tumour Biol,2015,36(8):5831-5837.
[8]	温馨,翟頔,王芳,等.miR-551b-3p在胃癌组织中低表达并抑制胃癌细胞系HGC-27的增殖、迁移和侵袭[J].基础医学与临床,2016,36(5):610-614.
[9]	宋宗昌,郭长升,赵鹏飞,等.下调PRR11表达抑制胃癌HGC-27细胞增殖和侵袭[J].胃肠病学和肝病学杂志,2016,25(11):1221-1224.
[10]	Peng WJ,Jia XJ,Wei BG,et al.Stomach cancer mortality among workers exposed to asbestos:a meta-analysis[J].J Cancer Res Clin Oncol,2015,141(7):1141-1149.
[11]	冯阳阳,陈婕,牟玲,等.抑制GM130表达对胃癌细胞增殖、侵袭及迁移能力的影响[J].第三军医大学学报,2015,37(12):1217-1221.
[12]	Wennerstrom ECM,Simonsen J,Camargo MC,et al.Acid-suppressing therapies and subsite-specific risk of stomach cancer[J].Bri J Cancer,2017,116(9):1234-1238.
[13]	Sitarz R,Polkowski WP,Maciejewski R,et al.Risk of peritoneal dissemination in stomach cancer[J].Curr Issues Pharmacy Med Sci,2017,30(4):184-186.
[14]	赵娟,田怡,李凡.八聚体结合蛋白-4对胃癌细胞增殖和侵袭能力的影响[J].海军医学杂志,2016,37(2):109-112.
[15]	Bertuccio P,Alicandro G,Rota M,et al.Citrus fruit intake and gastric cancer:The stomach cancer pooling(StoP)project consortium[J].Int J Cancer,2019,144(12):2936-2944.
[16]	丁顺斌,王简勤,蔡明春,等.miR-630在胃癌组织中的表达变化及对胃癌细胞SGC-7901增殖、侵袭能力的影响[J].山东医药,2017,57(15):9-12.
[17]	杨生辉,邱纯,李向璐,等.胃癌患者血清miR-183的表达水平及临床意义[J].中国中西医结合消化杂志,2019,27(8):613-617.
[18]	张亚琼,孙倩倩,娄欣欣,等.幽门螺杆菌感染相关miRNA-148 b在胃癌细胞增殖及侵袭中的分子机制研究[J].中华医院感染学杂志,2017,27(10):2177-2182.
[19]	Tamura T,Wada K,Tsuji M,et al.Association of alcohol consumption with the risk of stomach cancer in a Japanese population:a prospective cohort study[J].Eur J Cancer Prev,2018,27(1):27-32.
[20]	Ruiz EF,Torres-Roman JS,Servan SA,et al.Trends and geographic pattern of stomach cancer mortality in Peru[J].Cancer Epidemiol,2019,58:193-198.